enGene Holdings (ENGN)

Profile

Full Name

enGene Holdings Inc.

Ticker Symbol

ENGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

February 1, 2022

Indexes

Not included

Website

http://www.engene.com

Employees

56

Key Details

Price

$3.96(-1.00%)

Market cap

$201.87M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.46(+67.66% YoY)

PE ratio

-

Next earnings date

Jun 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.96
ENGN price is $3.96

30-Day Relative Volume

1.31
ENGN 30-day relative volume is 1.31

Price Performance

Price Today change

-1%
ENGN price is down -1% today

Price YTD change

-40.45%
ENGN price is down -40.45% since January 1st

Price 1-year change

-75.68%
ENGN price is down -75.68% year-on-year

Price 3-year change

-60.28%
ENGN price is down -60.28% over the past 3 years

Price Range

Price All-time high

$47.17
ENGN price is currently -91.60% below its historical high of $47.17

Price 3-year low

$3.50
ENGN price is currently +13.14% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$201.87M
ENGN market capitalization is $201.87 million

Market cap 3-year change

-
ENGN market capitalization 3-year change is unknown

Market cap All-time high

$794.92M
ENGN market capitalization is currently -74.60% below its historical high of $794.92 million

Market cap sector rank

58.26%
ENGN market capitalization is higher than 58.26% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+15.64%
ENGN shares outstanding is up +15.64% year-on-year

Shares Outstanding 3-Year Change

-
ENGN shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.36
ENGN beta is 0.36

200-day SMA

$7.07
ENGN price is currently -44.02% below its 200-day simple moving average

50-day SMA

$5.49
ENGN price is currently -27.88% below its 50-day simple moving average

RSI

32.52
ENGN 14-day relative strength index is 32.52

Volume

1.31
ENGN 30-day relative volume is 1.31

ATR

$0.53
ENGN average true range is $0.53

10-day Historical Volatility

86.45%
ENGN 10-day historical volatility is 86.45%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ENGN annual revenue value is unknown

Revenue Analysts estimate

-
ENGN annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ENGN annual revenue 1-year change is unknown

Revenue Sector rank

-
ENGN annual revenue is unknown

EPS

EPS

-$1.46
ENGN annual earnings per share is -$1.46

EPS Analysts estimate

-$1.96
ENGN annual earnings per share is currently -25.66% lower than the consensus analysts' forecast

EPS 1-year change

+67.66%
ENGN annual earnings per share is up +67.66% year-on-year

EPS Sector rank

46.33%
ENGN annual earnings per share is higher than 46.33% of companies in Healthcare sector

Profit

Gross profit

-
ENGN annual gross profit value is unknown

Gross margin

-
ENGN annual gross profit margin value is unknown

Operating profit

-$62.30M
ENGN annual operating income is -$62.30 million

Operating margin

-
ENGN annual operating profit margin value is unknown

Net income

-$55.14M
ENGN annual net profit is -$55.14 million

Net margin

-
ENGN annual net profit margin value is unknown

Expenses

Total expenses

$62.30M
ENGN annual total expenses is $62.30 million

Operating expenses

$62.30M
ENGN annual total operating expenses is $62.30 million

Cost of goods sold

-
ENGN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$22.10M
ENGN annual SGA is $22.10 million

Depreciation and amortization

$323.00K
ENGN annual depreciation & amortization is $323.00 thousand

Interest expense

$2.80M
ENGN annual interest expense is $2.80 million

Income tax

-$19.00K
ENGN annual income tax is -$19.00 thousand

EBIT & EBITDA

EBIT

-$52.36M
ENGN annual earnings before interest & taxes is -$52.36 million

EBITDA

-$52.04M
ENGN annual EBITDA is -$52.04 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$311.17M
ENGN annual total assets is $311.17 million

Non current assets

$63.81M
ENGN annual long term assets is $63.81 million

Current assets

$247.36M
ENGN annual total current assets is $247.36 million

Cash and cash equivalents

$173.00M
ENGN annual cash & cash equivalents is $173.00 million

Accounts receivable

-
ENGN annual accounts receivable value is unknown

Inventory

-
ENGN annual inventory value is unknown

Liabilities

Total liabilities

$38.56M
ENGN annual total liabilities is $38.56 million

Long term liabilities

$23.90M
ENGN annual total long term liabilities is $23.90 million

Current liabilities

$14.66M
ENGN annual total current liabilities is $14.66 million

Accounts payable

$1.41M
ENGN annual accounts payable is $1.41 million

Debt

Total debt

$25.02M
ENGN annual total debt is $25.02 million

Total debt 1-year change

+155.9%
ENGN annual total debt is up +155.9% year-on-year

Long term debt

$23.90M
ENGN annual long term debt is $23.90 million

Short term debt

$1.12M
ENGN annual short term debt is $1.12 million

Equity & Capital

Shareholders equity

$272.61M
ENGN annual stockholders equity is $272.61 million

Book value

$272.61M
ENGN annual book value is $272.61 million

Retained earnings

-$254.73M
ENGN annual retained earnings is -$254.73 million

Working capital

$232.70M
ENGN annual working capital is $232.70 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$48.28M
ENGN annual cash flow from operations is -$48.28 million

Cash from operations 1-year change

-95.13%
ENGN annual cash flow from operations is down -95.13% year-on-year

Cash from investing

-$125.95M
ENGN annual cash flow from investing activities is -$125.95 million

Cash from investing 1-year change

-39507.86%
ENGN annual cash flow from investing activities is down -39507.86% year-on-year

Cash from financing

$265.72M
ENGN annual cash flow from financing activities is $265.72 million

Cash from financing 1-year change

+208.44%
ENGN annual cash flow from financing activities is up +208.44% year-on-year

CAPEX

CAPEX

-
ENGN annual capital expenditures value is unknown

CAPEX 1-year change

-
ENGN annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$49.21M
ENGN annual free cash flow is -$49.21 million

Free cash flow 1-year change

-96.34%
ENGN annual free cash flow is down -96.34% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ENGN annual gross profit margin value is unknown

Operating margin

-
ENGN annual operating profit margin value is unknown

Net margin

-
ENGN annual net profit margin value is unknown

ROA & ROE

ROA

-17.72%
ENGN annual return on assets is -17.72%

ROE

-20.23%
ENGN annual return on equity is -20.23%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ENGN price to earnings ratio value is unknown

PE ratio Sector rank

-
ENGN price to earnings ratio is unknown

PB Ratio

PB ratio

0.81
ENGN price to book ratio is 0.81

PB ratio Sector rank

41.28%
ENGN price to book ratio is higher than 41.28% of companies in Healthcare sector

PS Ratio

PS ratio

-
ENGN price to sales ratio value is unknown

PS ratio Sector rank

-
ENGN price to sales ratio is unknown

Enterprise value

Enterprise value

$164.66M
ENGN enterprise value is $164.66 million

Enterprise value Sector rank

56.97%
ENGN enterprise value is higher than 56.97% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.51
ENGN EV/EBITDA is -2.51

EV/EBITDA Sector rank

27.69%
ENGN EV/EBITDA is higher than 27.69% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

16.87
ENGN annual current ratio is 16.87

Quick ratio

-
ENGN annual quick ratio value is unknown

Leverage

Debt to equity

0.09
ENGN annual debt to equity ratio is 0.09

Interest coverage ratio

-18.71
ENGN annual interest coverage ratio is -18.71

Risk & Stability

Piotroski F-Score

-
ENGN piotroski f-score value is unknown

Altman Z-Score

-
ENGN altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 11, 25 Morgan Stanley
Overweight
Mar 11, 25 HC Wainwright & Co.
Buy
Feb 18, 25 Piper Sandler
Overweight
Feb 14, 25 UBS
Neutral
Dec 23, 24 JMP Securities
Market Outperform
Dec 23, 24 HC Wainwright & Co.
Buy
Dec 6, 24 JMP Securities
Market Outperform
Nov 27, 24 Raymond James
Outperform
Nov 18, 24 JMP Securities
Market Outperform
Sep 24, 24 Oppenheimer
Outperform

Institutional Ownership

Similar stocks

ABEO logo
Abeona Therapeutics (ABEO)
DRUG logo
Bright Minds Biosciences (DRUG)
IMMP logo
Immutep Limited (IMMP)
SLDB logo
Solid Biosciences (SLDB)
LUNG logo
Pulmonx (LUNG)
NVCT logo
Nuvectis Pharma (NVCT)
PDEX logo
Pro-Dex (PDEX)
ITOS logo
iTeos Therapeutics (ITOS)
YMAB logo
Y-mAbs Therapeutics (YMAB)
  • What is the ticker symbol for enGene Holdings?
  • Does enGene Holdings pay dividends?
  • What sector is enGene Holdings in?
  • What industry is enGene Holdings in?
  • What country is enGene Holdings based in?
  • When did enGene Holdings go public?
  • Is enGene Holdings in the S&P 500?
  • Is enGene Holdings in the NASDAQ 100?
  • Is enGene Holdings in the Dow Jones?
  • When was enGene Holdings's last earnings report?
  • When does enGene Holdings report earnings?
  • Should I buy enGene Holdings stock now?

What is the ticker symbol for enGene Holdings?

The ticker symbol for enGene Holdings is NASDAQ:ENGN

Does enGene Holdings pay dividends?

No, enGene Holdings does not pay dividends

What sector is enGene Holdings in?

enGene Holdings is in the Healthcare sector

What industry is enGene Holdings in?

enGene Holdings is in the Biotechnology industry

What country is enGene Holdings based in?

enGene Holdings is headquartered in Canada

When did enGene Holdings go public?

enGene Holdings's initial public offering (IPO) was on February 1, 2022

Is enGene Holdings in the S&P 500?

No, enGene Holdings is not included in the S&P 500 index

Is enGene Holdings in the NASDAQ 100?

No, enGene Holdings is not included in the NASDAQ 100 index

Is enGene Holdings in the Dow Jones?

No, enGene Holdings is not included in the Dow Jones index

When was enGene Holdings's last earnings report?

enGene Holdings's most recent earnings report was on Mar 10, 2025

When does enGene Holdings report earnings?

The next expected earnings date for enGene Holdings is Jun 13, 2025

Should I buy enGene Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page